Biotech Hunter
Biotech Hunter
Home
Companies
Trials
People
Search
Clinical Trials Directory
Explore 118,444 clinical trials worldwide
Search
Showing 86601-86650 of 118,444 trials
Active filters:
Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting
Clinical Trials (118,444)
NCT05376423
To Evaluate OBI-833/OBI-821 in Patients With Locally Advanced, Globo H-Positive Esophageal Cancer for Recurrence
PHASE2
Recruiting
60 participants
Started: Jun 2, 2022 · Completed: Jun 30, 2025
1 condition
1 sponsor
1 location
NCT05243862
Safety and Activity of PolyPEPI1018 Plus Atezolizumab in Colorectal Cancer.
PHASE2
Active, not recruiting
18 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition
3 sponsors
3 locations
NCT05268094
Comparison of Methods of Pulmonary Blood Flow Augmentation in Neonates: Shunt Versus Stent (The COMPASS Trial)
NA
Recruiting
300 participants
Started: Jun 2, 2022 · Completed: Apr 1, 2027
1 condition
2 sponsors
24 locations
NCT05321875
Early Treatment With Candesartan vs Placebo in Genetic Carriers of Dilated Cardiomyopathy (EARLY-GENE Trial)
PHASE3
Recruiting
320 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2026
1 condition
1 sponsor
1 location
NCT05195632
Phase II Study Investigating the Combination of Encorafenib and Binimetinib in BRAF V600E Mutated Chinese Patients With Metastatic Non-Small Cell Lung Cancer
PHASE2
Active, not recruiting
63 participants
Started: Jun 2, 2022 · Completed: Sep 5, 2026
1 condition
1 sponsor
34 locations
NCT05282485
Mitigating Infectious Morbidity and Growth Deficits in HIV Exposed Uninfected infanTs With Human Milk Oligosaccharides
NA
Active, not recruiting
140 participants
Started: Jun 2, 2022 · Completed: Sep 10, 2027
3 conditions
5 sponsors
1 location
NCT05417906
Using the Blood Eosinophil Count to Guide Systemic Corticosteroid Treatment in Asthma Exacerbations
PHASE2
Active, not recruiting
110 participants
Started: Jun 2, 2022 · Completed: Sep 30, 2026
2 conditions
2 sponsors
2 locations
NCT05357313
Adjunctive Bright Light Therapy in Patients With Bipolar Depression and Eveningness
NA
Recruiting
70 participants
Started: Jun 2, 2022 · Completed: Feb 28, 2026
1 condition
1 sponsor
1 location
NCT05528354
Venetoclax and Decitabin Based Conditioning Regimen Followed With Post-HSCT Decitabin Maintenance Therapy in TP53 Mutant AML/MDS Patients
EARLY_PHASE1
Recruiting
58 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT06158789
Repetitive Blood Brain Barrier Opening for Alzheimer's Disease.
NA
Active, not recruiting
6 participants
Started: Jun 2, 2022 · Completed: Jan 19, 2024
1 condition
2 sponsors
1 location
NCT03856515
Gender Differences in Switching From Smoking Regular Cigarettes to E-Cigarettes
NA
Active, not recruiting
169 participants
Started: Jun 2, 2022 · Completed: Aug 31, 2026
1 condition
2 sponsors
1 location
NCT05204147
Actinium 225 Labeled Anti-CEA Antibody (Ac225-DOTA-M5A) for the Treatment of CEA Producing Advanced or Metastatic Cancers
PHASE1
Recruiting
20 participants
Started: Jun 2, 2022 · Completed: Jul 21, 2026
2 conditions
2 sponsors
1 location
NCT05367440
Study of AZD5305 When Given in Combination With New Hormonal Agents in Patients With Metastatic Prostate Cancer
PHASE1/PHASE2
Recruiting
175 participants
Started: Jun 2, 2022 · Completed: Apr 17, 2031
1 condition
2 sponsors
27 locations
NCT05276310
A Study of IMC-002 in Patients With Advanced Cancer Failed to Standard Therapy
PHASE1
Recruiting
62 participants
Started: Jun 2, 2022 · Completed: Aug 30, 2029
1 condition
1 sponsor
3 locations
NCT05409261
Evaluation of the Immunogenicity and Safety of Ad26.COV2.S's COVID-19 Vaccine
PHASE2
Active, not recruiting
200 participants
Started: Jun 2, 2022 · Completed: Mar 31, 2025
4 conditions
6 sponsors
1 location
NCT05819463
Treatment and Medical Care of Patients With Moderate-to-severe Atopic Dermatitis - TREATswitzerland
N/A
Recruiting
700 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2032
1 condition
1 sponsor
9 locations
NCT05234866
Paradoxical Lucidity in Severe End-Stage Dementia
N/A
Recruiting
520 participants
Started: Jun 2, 2022 · Completed: May 31, 2026
1 condition
2 sponsors
1 location
NCT05115110
A Study to Investigate the Safety and Efficacy of RO7204239 in Combination With Risdiplam (RO7034067) in Participants With Spinal Muscular Atrophy
PHASE2/PHASE3
Active, not recruiting
259 participants
Started: Jun 2, 2022 · Completed: Feb 27, 2029
1 condition
1 sponsor
35 locations
NCT04755205
A Natural History Study of Children and Adults With Olfactory Neuroblastoma
N/A
Recruiting
525 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2029
2 conditions
1 sponsor
1 location
NCT05428969
A Study to Assess Safety, Tolerability and Preliminary Efficacy of Bexmarilimab in Combination With Standard of Care in Patients With Hematological Malignancies
PHASE1/PHASE2
Active, not recruiting
181 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
4 conditions
1 sponsor
10 locations
NCT05608603
Diagnostics of Coronavirus Disease 2019 Cardiovascular Complications
N/A
Enrolling by invitation
100 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2025
6 conditions
1 sponsor
1 location
NCT05239624
Enfortumab Vedotin and Pembrolizumab in People With Bladder Cancer
PHASE2
Recruiting
23 participants
Started: Jun 2, 2022 · Completed: Jun 30, 2026
1 condition
4 sponsors
10 locations
NCT05112601
Testing Nivolumab With or Without Ipilimumab in Deficient Mismatch Repair System (dMMR) Recurrent Endometrial Carcinoma
PHASE2
Recruiting
81 participants
Started: Jun 2, 2022 · Completed: Apr 30, 2026
9 conditions
2 sponsors
111 locations
NCT06272669
Cumulative and Booster Effects of Multisession Prefrontal TDCS in ASD Adolescents
NA
Recruiting
90 participants
Started: Jun 2, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT05652062
Prizvalve® Transcatheter Valve-in-Valve Implantation Exploratory Study
NA
Recruiting
5 participants
Started: Jun 2, 2022 · Completed: Jun 2, 2024
1 condition
2 sponsors
1 location
NCT05252078
Anlotinib Hydrochloride Capsules Combined With TQB2450 Injection in Esophageal Squamous Cell Carcinoma Patients
PHASE2
Recruiting
30 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2026
11 conditions
2 sponsors
1 location
NCT05454787
Ondexxya for Intravenous Injection 200mg Drug Use Result Investigation (All Case Investigation)
N/A
Recruiting
300 participants
Started: Jun 2, 2022 · Completed: Nov 30, 2025
2 conditions
1 sponsor
89 locations
NCT05414253
Evaluation of Chlorhexidine Plus Hyaluronic Acid Mouthwash in Surgical Wound Healing Following Third Molar Surgery (CLOR_4)
NA
Recruiting
54 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
3 conditions
1 sponsor
1 location
NCT07029841
Cohort Study on Treatment Comes of Catheter-based Therapy in Patients With Acute Pulmonary Embolism in Hong Kong
N/A
Recruiting
1,000 participants
Started: Jun 1, 2022 · Completed: Dec 30, 2032
3 conditions
2 sponsors
1 location
NCT04797481
Pilot Testing of an Online Rehabilitation Intervention for People With Heart Failure (PORIAS-HF).
NA
Enrolling by invitation
40 participants
Started: Jun 1, 2022 · Completed: Jul 30, 2025
1 condition
3 sponsors
1 location
NCT06500767
Psycho-emotional Impact of Preoperative Counselling in Cervico-carcinoma Screening Programs
N/A
Recruiting
300 participants
Started: Jun 1, 2022 · Completed: Jul 31, 2025
3 conditions
1 sponsor
1 location
NCT05524649
Effect of Probiotics on Infant's Fecal Microbiota Composition
NA
Recruiting
120 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
2 sponsors
2 locations
NCT04397159
Effects of Combination Exercise on Fatigability in Veterans With Chronic Kidney Disease
NA
Recruiting
30 participants
Started: Jun 1, 2022 · Completed: Apr 1, 2026
1 condition
1 sponsor
1 location
NCT05566002
Artificial Intelligence-assisted Evaluation of Pulmonary HYpertension
N/A
Recruiting
2,000 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
2 conditions
1 sponsor
1 location
NCT05347641
Penpulimab Combined With RMA Treatment of Primary Diagnosis of Primary Central Nervous System Lymphoma
PHASE2
Not yet recruiting
23 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2029
1 condition
1 sponsor
0 locations
NCT05400239
SOTO: Treatment Sensitivity of Organoids to Predict Treatment Outcome
N/A
Recruiting
60 participants
Started: Jun 1, 2022 · Completed: Jun 30, 2025
2 conditions
1 sponsor
1 location
NCT05792202
Combined Microfracture Procedure Promotes Tendon Healing
NA
Recruiting
50 participants
Started: Jun 1, 2022 · Completed: Jun 1, 2026
3 conditions
1 sponsor
1 location
NCT05991167
"EndeavorRx® Prospective Product Registry (Expedition EndeavorRx)"
N/A
Active, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
1 location
NCT05361161
Transarterial Chemoembolization With Lipiodol in the Treatment of Initial Unresectable Gastric Cancer (GC)
PHASE2
Not yet recruiting
60 participants
Started: Jun 1, 2022 · Completed: Dec 1, 2025
2 conditions
1 sponsor
0 locations
NCT06177210
Type 2 Diabetes Remission
N/A
Active, not recruiting
20 participants
Started: Jun 1, 2022 · Completed: Aug 30, 2025
1 condition
2 sponsors
1 location
NCT05409352
Self-administered Acupressure to Improve Cancer-related Fatigue Among Cancer Patients Undergoing Chemotherapy
NA
Recruiting
138 participants
Started: Jun 1, 2022 · Completed: May 31, 2025
4 conditions
1 sponsor
1 location
NCT05518331
The Safety and Efficacy Study of Avatrombopag Switch in TPO-RA Refractory AA
NA
Recruiting
39 participants
Started: Jun 1, 2022 · Completed: Jan 1, 2026
1 condition
6 sponsors
1 location
NCT05441696
Study for the Evaluation of a Non-invasive Hemodynamic Measurement in Heart Failure Patients
N/A
Enrolling by invitation
65 participants
Started: Jun 1, 2022 · Completed: Sep 29, 2026
1 condition
1 sponsor
2 locations
NCT05075161
Pirfenidone to Prevent Fibrosis in Ards.
PHASE3
Recruiting
130 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
1 condition
1 sponsor
17 locations
NCT04808206
A Registry of Laparoscopic Bariatric Surgery Using Stapling Devices: Observation of Safety and Clinical Efficacy
N/A
Active, not recruiting
150 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
4 conditions
1 sponsor
3 locations
NCT05062915
Diagnostic Work up and Management of Acute Onset Vertigo
NA
Active, not recruiting
90 participants
Started: Jun 1, 2022 · Completed: Jul 1, 2025
2 conditions
1 sponsor
1 location
NCT05361772
Low-dose Colchicine Inhibit Abdominal Aortic Aneurysm Growth Trial
NA
Not yet recruiting
230 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2025
3 conditions
8 sponsors
0 locations
NCT05216185
The Assessment of Bone Health in a Clinical Setting
N/A
Not yet recruiting
5,000 participants
Started: Jun 1, 2022 · Completed: Feb 28, 2027
1 condition
1 sponsor
0 locations
NCT07032103
Prospective Cohort Study for Lymphoma: Samsung Lymphoma Cohort Study IV
N/A
Recruiting
2,000 participants
Started: Jun 1, 2022 · Completed: Dec 30, 2028
1 condition
1 sponsor
1 location
NCT05426616
Titanium Reinforced d-PTFE Membrane Versus Collagen Membrane For Guided Bone Regeneration
NA
Recruiting
36 participants
Started: Jun 1, 2022 · Completed: Dec 31, 2028
1 condition
1 sponsor
3 locations
Previous
1
More pages
1730
1731
1732
1733
1734
1735
1736
More pages
2369
Next